Trading status Status de
  • Prices realtime
    • Indizes
      • UC DAX
      • UC MDAX
      • UC TECDAX
      • UC DJI
      • UC ESTOXX
      • UC NASQAD 100
    • Shares
    • ETFs & FUNDS
    • Bonds
    • Crypto
  • Screen markets
    • Stock screener
    • Certifcate Screener
    • ETF Screener
    • Fund Screener
    • Bond screener
  • Trading ideas
    • risk indices
      • risk indices
      • EU Intraday
      • EU Long Term
      • US Intraday
      • US Longterm
    • New on gettex
      • New listings stocks
      • New listings bonds
      • New intraday certificates
    • Blog
    • Newsletter
    • Watchlist
    • Support
  • Trading
    • Trading Calendar
    • Extended trading hours
    • Listing on demand
    • Announcements
    • Quality Reports
    • Delayed Data
    • Regulations
    • Become a Trade Participant
    • Cancellations
  • About Gettex
    • FAQs
    • Press
    • Partners
    • Committees
    • Career
    • Service & Contact
  • Why gettex

News overview

  • «
  • ‹
  • …
  • 6168
  • 6169
  • 6170
  • …
  • ›
  • »

2026-03-16

W&T Offshore Announces Final Fourth Quarter and Full Year 2025 Results, Including Year-End 2025 Proved Reserves and Provides Guidance for 2026

2026-03-16

Regal Rexnord Provides Update on CEO Succession Process

2026-03-16

What′s Behind a New $12 Million Investment in a Flooring Chain Stock Down 33% This Past Year?

2026-03-16

Autolus Therapeutics to Report Fourth Quarter and Full Year 2025 Financial Results and Host Conference Call on March 27, 2026

2026-03-16

INTEGRA ADDED TO GDXJ JUNIOR GOLD MINERS ETF

2026-03-16

Scinai Immunotherapeutics Receives Nasdaq Notification Regarding Minimum Bid Price

2026-03-16

Perspective Therapeutics Provides Recent Business Highlights and Reports Full Year 2025 Results

2026-03-16

Benchmark Electronics Announces Quarterly Cash Dividend

2026-03-16

Cerus Appoints Vivek Jayaraman as President and Chief Executive Officer

2026-03-16

Pega Announces Quarterly Cash Dividend for Second Quarter of 2026

2026-03-16

FibroGen GAAP EPS of -$3.51 beats by $0.37, revenue of $1.27M misses by $0.4M

2026-03-16

INNOVATE Corp. to Report Fourth Quarter and Full Year 2025 Results on March 26th

  • «
  • ‹
  • …
  • 6168
  • 6169
  • 6170
  • …
  • ›
  • »

Preset online depot

Favorites: Zertifikate-Finder FAQs Newsletter
Tradingtime Mo-Fr: 7:30-23 h
Certificates 8:00-22 h
  • Imprint
  • Legal notice
  • Data protection
  • Contact
  • Cookies